{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:21:05Z","timestamp":1770290465917,"version":"3.49.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive neurometabolic disorder leading to severe combined serotonin, dopamine, norepinephrine, and epinephrine deficiency. We report on a female patient with borderline functioning and sporadic clear-cut focal to bilateral seizures from age 10\u2009years. A neuropsychological assessment highlighted a mild impairment in executive functions, affecting attention span and visual\u2013spatial abilities. Following the diagnosis of epilepsy with a presumed genetic etiology, we applied a diagnostic approach inclusive of a next-generation sequencing (NGS) gene panel, which uncovered two variants <jats:italic>in trans<\/jats:italic> in the DOPA decarboxylase (<jats:italic>DDC<\/jats:italic>) gene underlying an AADC deficiency. This compound heterozygous genotype was associated with a mild reduction of homovanillic acid, a low level of the norepinephrine catabolite, and a significant reduction of 5-hydroxyindoleacetic acid in cerebrospinal fluid. Remarkably, 3-O-methyldopa (3-OMD) and 5-hydroxytryptophan were instead increased. During the genetically guided re-evaluation process, some mild signs of dysautonomic dysfunction (nasal congestion, abnormal sweating, hypotension and fainting, excessive sleepiness, small hands and feet, and increased levels of prolactin, tiredness, and fatigue), more typical of AADC deficiency, were evaluated with new insight. Of the two AADC variants, the R347Q has already been characterized as a loss-of-function with severe catalytic impairments, while the novel L391P variant has been predicted to have a less severe impact. Bioinformatic analyses suggest that the amino acid substitution may affect affinity for the PLP coenzyme. Thus, the genotype corresponds to a phenotype with mild and late-onset symptoms, of which seizures were the clinical sign, leading to medical attention. This case report expands the spectrum of AADC deficiency phenotypes to encompass a less-disabling clinical condition including borderline cognitive functioning, drug-responsive epilepsy, and mild autonomic dysfunction.<\/jats:p>","DOI":"10.3389\/fneur.2023.1284339","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T07:55:55Z","timestamp":1701849355000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case report: Childhood epilepsy and borderline intellectual functioning hiding an AADC deficiency disorder associated with compound heterozygous DDC gene pathogenic variants"],"prefix":"10.3389","volume":"14","author":[{"given":"Ida","family":"Cursio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Siliquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Carducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Bisello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Bertoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Marini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF01799380","article-title":"Aromatic amino acid decarboxylase deficiency in twins","volume":"13","author":"Hyland","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"107624","DOI":"10.1016\/j.ymgme.2023.107624","article-title":"Prevalence of DDC genotypes in patients with aromatic L-amino acid decarboxylase (AADC) deficiency and in silico prediction of structural protein changes","volume":"139","author":"Himmelreich","year":"2023","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1073\/pnas.69.2.343","article-title":"On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine)","volume":"69","author":"Christenson","year":"1972","journal-title":"Proc Nat Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/8904_2014_295","article-title":"Report of two never treated adult sisters with aromatic L-amino acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?","volume":"15","author":"Leuzzi","year":"2015","journal-title":"JIMD Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic lamino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2210555","article-title":"Clinical features in aromatic L-amino acid decarboxylase (AADC) deficiency: a systematic review","volume":"2022","author":"Rizzi","year":"2022","journal-title":"Behav Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jimd.12247","article-title":"AADC deficiency from infancy to adulthood: symptoms and developmental outcome in an international cohort of 63 patients","volume":"43","author":"Pearson","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2352-4642(17)30125-6","article-title":"Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1\/2 trial","volume":"1","author":"Chien","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.25467","article-title":"Gene therapy improves brain white matter in aromatic l-amino acid decarboxylase deficiency","volume":"85","author":"Tseng","year":"2019","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"134ra61","DOI":"10.1126\/scitranslmed.3003640","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","volume":"4","author":"Hwu","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/brain\/awy331","article-title":"Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency","volume":"142","author":"Kojima","year":"2019","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat Commun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12649","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency: requirements for safe application and knowledge-generating follow-up","author":"Roubertie","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/jcmm.14768","article-title":"Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis","volume":"24","author":"Han","year":"2020","journal-title":"J Cell Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/jcmm.14887","article-title":"Whole exome sequencing identified a homozygous novel variant in CEP290 gene causes Meckel syndrome","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jcmm.13979","article-title":"Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy","volume":"23","author":"Dai","year":"2019","journal-title":"J Cell Mol Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fgene.2018.00129","article-title":"Whole exome sequencing identified a novel heterozygous mutation in HMBS gene in a Chinese patient with acute intermittent Porphyria with rare type of mild Anemia","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Genet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41592-022-01685-y","article-title":"AlphaFill: enriching AlphaFold models with ligands and cofactors","volume":"20","author":"Hekkelman","year":"2023","journal-title":"Nat Methods"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"11238","DOI":"10.3390\/ijms231911238","article-title":"Compound heterozygosis in AADC deficiency and its complex phenotype in terms of AADC protein population","volume":"23","author":"Bisello","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1093\/hmg\/ddu266","article-title":"A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications","volume":"23","author":"Montioli","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbapap.2016.03.011","article-title":"The novel R347G pathogenic mutation of aromatic amino acid decarboxylase provides additional molecular insights into enzyme catalysis and deficiency","volume":"1864","author":"Montioli","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymgme.2019.05.004","article-title":"A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: clinical aspects and biochemical studies","volume":"127","author":"Montioli","year":"2019","journal-title":"Mol Genet Metab"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"108263","DOI":"10.1016\/j.abb.2020.108263","article-title":"New variants of AADC deficiency expand the knowledge of enzymatic phenotypes","volume":"682","author":"Montioli","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbrc.2023.06.065","article-title":"Exome sequencing data screening to identify undiagnosed Aromatic l-amimno acid decarboxylase deficiency in neurodevelopmental disorders","volume":"673","author":"Riva","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ymgme.2021.03.009","article-title":"Detection of 3-O-methyldopa in dried blood spots for neonatal diagnosis of aromatic L-amino-acid decarboxylase deficiency: the northeastern Italian experience","volume":"133","author":"Burlina","year":"2021","journal-title":"Mol Genet Metab"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejpn.2008.03.008","article-title":"Aromatic L-amino acid decarboxylase deficiency in Taiwan","volume":"13","author":"Lee","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/jnc.14893","article-title":"Dopamine beta-hydroxylase and its genetic variants in human health and disease","volume":"152","author":"Gonzalez-Lopez","year":"2020","journal-title":"J Neurochem"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.12.005","article-title":"Regulation of the dopaminergic system in a murine model of aromatic Lamino acid decarboxylase deficiency","volume":"52","author":"Lee","year":"2013","journal-title":"Neurobiol Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","article-title":"Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/epi4.12580","article-title":"Serotonin receptors in epilepsy: novel treatment targets?","volume":"7","author":"Sourbron","year":"2022","journal-title":"Epilepsia Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/mdc3.12622","article-title":"Successful pregnancy in a patient with L-amino acid decarboxylase deficiency: therapeutic management and clinical outcome","volume":"5","author":"Mastrangelo","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2022.08.033","article-title":"Al long-term neurological and psychiatric outcomes in patients with aromatic l-amino acid decarboxylase deficiency","volume":"103","author":"Manti","year":"2022","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1284339\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T07:55:58Z","timestamp":1701849358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1284339\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":35,"alternative-id":["10.3389\/fneur.2023.1284339"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1284339","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"article-number":"1284339"}}